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Objective: Dispensing of antibiotics without a prescription (DAwP) has been widely practised among 
community pharmacies in Saudi Arabia despite being illegal. However, in May 2018, the law and 
regulations were enforced alongside fines. Consequently, we wanted to evaluate the impact of these 
changes.  
Methods: A study was conducted among 116 community pharmacies in two phases. Pre-law 
enforcement phase between December 2017 and March 2018 and a post-law enforcement phase a 
year later. Each phase consisted of a cross-sectional questionnaire-based survey and a simulated 
client method (SCM).  In the SCM, clients presented with either pharyngitis or urinary tract infections 
(UTI). In SCM, for each phase, all 116 pharmacies were visited with one of the scenarios.  
Results: Before the law enforcement, 70.7 % reported that DAwP was common with 96.6% and 
87.7% of participating pharmacies dispensed antibiotics without a prescription for pharyngitis and UTI 
respectively. After the law enforcement, only 12.9% reported that DAwP is still a common practice, 
with only 12.1% and 5.2% dispensing antibiotics without prescriptions for pharyngitis and UTI 
respectively. 
Conclusion: law enforcement was effective. However, there is still further scope for improvement. 
This could include further educational activities with pharmacists, physicians and the public.  
Keywords: Dispensing antibiotics without prescriptions, community pharmacy, law enforcement, 













x There was considerable dispensing of antibiotics among community pharmacists in Saudi Arabia 
despite legislation banning this 
x In May 2018, greater enforcement of the dispensing of antibiotics without a prescription (DAwP) 
took place with imposing of fines up to 100,000 SR (equivalent to US$26,666) and cancellation of 
the licence in case of violations 
x This resulted in a considerable reduction on DAwP with only 12.9% of community pharmacists 
reporting that DAwP is still a common practice, with only 12.1% and 5.2% of pharmacists 
dispensing antibiotics without prescriptions for pharyngitis and UTI respectively; with this typically 
only occurring following specific requests 
x However, there is still a need for greater educational activities among all key stakeholder groups 
including patients to reduce expectations of being prescribed or dispensed an antibiotic for 
essentially self-limiting conditions 






Irrational use of antibiotics is a major factor responsible for the global spread of antimicrobial 
resistance (AMR) worldwide [1-4], with AMR known to increase morbidity, mortality, and healthcare 
costs [5-8]. These concerns are leading to multiple initiatives globally, regionally and nationally to 
improve antibiotic utilisation thereby hoping to reduce AMR rates in the future [2,9-15]. One of the 
principal activities contributing to the irrational use of antibiotics is the dispensing of antibiotics without 
a prescription (DAwP) for principally self-limiting conditions such as upper respiratory tract infections 
(URTIs) as well as urinary tract infections (UTIs) [16-14]. This is because DAwP is frequently 
associated with inappropriate drug choices, doses and uses [16,25-28], with community pharmacies 
considered to be the main source for non-prescription antibiotics [16,19,29,30]. DAwP is particularly 
prevalent in LMICs accounting for up to 93% or more of dispensed antibiotics [17,19,20,24]. DAwP is 
enhanced by high levels of co-payment in low- and middle-income countries (LMICs), difficulties in 
access and affordability of physicians, commercial pressures on pharmacy staff as well as patient and 
parent pressure on pharmacists to dispense an antibiotic [17,19,20,31-33]. Overall, with up to 100% 
of pharmacists dispense antibiotics without a prescription despite legislation banning this in some 
LMICs [24,34]. This situation is very different to for instance Northern European countries with their 
universal healthcare systems, easier access to physicians, tight control over dispensing activities 
among community pharmacies and typically reducing antimicrobial utilisation versus LMICs [26,35-
37].  
Whilst DAwP is illegal in most countries and despite concerns, it is still widely practiced and estimated 
to represent more than 50% of antibiotics consumed worldwide [16-19,21,23,38-40]. DAwP is not 
limited to low- and middle- income countries (LMICs) as this practice is also seen in high income 
countries [25,41-43]. Non-prescription sales of antibiotics have been documented in a number of 
systematic reviews, with  Morgan et al. (2011) documenting that DAwP accounted for between 19 to 
100% of total antimicrobial use outside of northern Europe and North America [26]. Ocan et al. (2015) 
in their review involving LMICs found an overall prevalence of 38.8 % for antimicrobial DAwP [18]. 
Sakeena et al. (2018) in their systematic review of 50 studies in LMICs also found high rates of non-
prescription sales of antibiotics at up to 100% in some countries [19].  Nepal et al. (2018) in their 
review also found high rates of DAwP ranging from 7.3% to 85.59% with an overall prevalence of 
42.64% [17]. More recently, Auta et al. (2019) in their review and meta-analysis including 38 studies 
from 24 countries reported that the overall percentage of non-prescription supply of antibiotics was 
62% [16]. 
 
In the Middle East, DAwP continues to be a serious problem [21,38,39,44-52]. Similarly, in Saudi 
Arabia, DAwP has been a long standing issue during the past four decades despite the fact that 
DAwP is illegal according to the Law of Practice of Health Professions in Saudi Arabia [52]. The law 
stipulated that pharmacists are obliged to dispense medicines on prescription only, except those 











this law, many studies conducted across Saudi Arabia over the past years have shown that non-
adherence to the law is common [54-62]. For example, Al-Freihi et al. (1987) reported that in 1983, 
85% of community pharmacies in the Eastern Province of Saudi Arabia dispensed antibiotics without 
prescription [55]. Similarly, in 2001, Al-Ghamdi reported that 82% of community pharmacists in the 
Eastern Province dispensed antibiotics over counter [56], with Abdulhak et al. (2011) in Riyadh 
showing that 77.6% of community pharmacists handed out antibiotics based on simulated patient 
requests without a prescription [54]. In their study, Emeka et al. (2014) found that colds and sore 
throats were the most common reasons for seeking DAwP [61]. 
 
These high levels are not surprising since DAwP is not only linked to the lack of legislation that 
prohibits this practice, but also linked to poor enforcement of these regulations 
[20,21,33,34,38,53,63]. There are also other factors driving DAwP. These include (i) easy access to 
antimicrobials, (ii) a e  be ef  ab  a b c  speeding up their recovery, (iii) commercial 
pressures on pharmacists, (iv) pressures from patients and parents on pharmacists to dispense 
antimicrobials, (iv) issues of affordability whereby patients cannot afford to see both a physician and 
purchase their medicines, (v) the level of education among patients, (vi) long travelling distances to 
see a physician in a public healthcare centre (PHC) in some countries versus visiting a local 
pharmacist impacting on potential earnings as well as the cost of travelling, (vii) variable knowledge 
about antibiotics and AMR among community pharmacists, (viii) and PHCs being out-of-stock of 
medicines with patients subsequently referred to their local pharmacists anyway to obtain their 
antibiotics [16,18-21,43,64-69]. 
 
The variety of reasons for DAwP have resulted in a range of different activities across countries to try 
and reduce the extent of self-purchasing of antibiotics along with other measures to improve the 
rational utilisation of antibiotics within a country, with typically multiple measures and initatives needed 
to improve future utilisation especially in LMICs [12,13,33,70-72]. I c ea  a ac  ed e 
has also helped reduce DawP, with pharmacists often the first healthcare professional that patients 
consult with regarding URTIs, UTIs and paediatric diarrhoea [24,40,64,73-76]. The importance of 
pharmacists as essential players providing information to patients, encouraging the prudent use of 
antibiotics, and giving proper advice and counselling to patients when dispensing antibiotics, is 
highlighted by suggested activities and standards promulgated by FIP (International Federation of 
Pharmacists) and the WHO [29,30]. 
There have been a number of initiatives among countries to enforce the laws governing DAwP 
including either incentives such as fines, sanctions including the suspension of the license or closure 
of the pharmacy, or both. Some of these initiatives and their impact where known are documented in 
Table 1 building on a recent systematic review concerning the impact of legislation to reduce DAwP 
[77-79]. 
 
There have been calls for the government in Saudi Arabia to enforce legislation banning DAwP in 
view of current concerns [93]. As a result in May 2018, a number of activities were instigated by the 
Saudi Ministry of Health to enforce the law and regulations prohibiting DAwP. Before, May 2018, the 
regulations were existed; however, they were not typically implemented and antibiotics were 
dispensed widely without a prescription and no legal actions were taken against those pharmacists 
who violated the law. However, in May 2018, the law was enforced and Ministry of Health through its 
official website and its other social media pages announced the enforcement of the law and that 
violators will face legal actions including imposing fines up to 100,000 SR (equivalent to US$26,666) 
and cancellation of the licence in case of violations [94].  
 
Whilst a number of studies have been undertaken across countries to analyse the impact of greater 
enforcement of regulations surrounding DAwP with varying success (Table 1), to the best of our 
knowledge, we believe no study has yet been conducted to evaluate the impact of this initiative in 
Saudi Arabia. We believe this is an important gap to address since an evaluation can inform health 
policy makers and the health regulators in Saudi Arabia and wider about the effectiveness of 
introduced measures including extensive fines to provide future guidance. In addition, such an 
analysis would help in providing a basis for discussing the need for any additional interventions in 
Saudi Arabia if required. Consequently, in this study we aimed to evaluate whether the activities of 
law enforcement and the potential for substantive fines had resulted in improved community 














2.1 Study design  
We adopted a pre- and post-law enforcement multi-methods study design [95]. The research project 
was conducted in two phases - before and after law enforcement and fines. Each phase consisted of 
two different methods, namely a cross-sectional questionnaire-based survey and a simulated client 
method (SCM).  
 
This multi-method approach was adopted because the literature suggests that using tools that 
measure only self-reported practices could be prone to social desirability bias, which is the tendency 
of participants to choose socially acceptable responses rather than choosing responses that reflect 
their true feelings or practices [96]. In addition, the simulated client method is a well-recognized 
technique to reliably assess practices and behaviour including any malpractices in community 
pharmacies [19,23,24,40,97-99]. In the SCM, a three-steps design was implemented in the simulated 
patient scenarios to investigate the claim commonly reported in the literature that pharmacists 
dispense antibiotics without prescription because of the pressure exerted by patients [20,66,74,100].  
 
The pre-law enforcement phase of the study was conducted between December 2017 and March 
2018, while the post-law enforcement phase was conducted a year later from December 2018 to 
March 2019 after the Saudi Ministry of Health (SMOH) imposed law enforcement in May 2018. The 
study scheme is presented in Figure 1.   
 
 
2.2 Data collection 
The study used a structured, face and content validated, and pilot-tested questionnaire in the first part 
of each phase. The questionnaire was adopted from the literature, including the work of Hadi et al. 
(2016) [74]. T e e a e a  de ed  e c  f a   c  a ac  
knowledge, attitudes and practices regarding DAwP. Data collection was conducted twice in 
December 2017 (1st phase before law enforcement) and December 2018 (2nd phase after law 
enforcement). To administer the questionnaires, four data collectors were involved in the distribution 
of the questionnaires (two for each phase) and visiting the community pharmacies. During the visit to 
each pharmacy, data collectors sought permission from pharmacists after introducing themselves and 
explaining the purpose of the study before asking them to complete the questionnaires. These were 
self-administered questionnaires, and the role of data collectors was limited to the distribution of 
questionnaires. In addition, all the participants were assured that their responses would be treated 
confidentially and would only be used for research purposes.   
 
In the second part of each phase, a simulated client Method (SCM) was adopted. The same 
community pharmacists who completed the questionnaires were visited again after two months from 
completing the questionnaire by two simulated patients other than those who delivered the 
questionnaires to them. Four simulated patients, who were pharmacy students, were trained to 
approach pharmacy staff, present clinical scenarios of either pharyngitis or urinary tract infections 
(UTI) in each community pharmacy since, as mentioned, they are the typical infections presenting to 
community pharmacists [16,18-20,39,49,101]. We have chosen the scenario of pharyngitis as the 
current literature suggests that it is common practice to dispense antibiotics for URTIs at community 
pharmacies in Saudi Arabia although this practice is not evidence-based as antibiotics are typically 
not needed in most URTIs, e.g. the study of Abdulhak et al (2011) showed that for URTIs antibiotics 
were dispensed in 90% of cases in Saudi Arabia [23,33,54,74]. In the second scenario, UTIs are also 
a common scenario used in literature. In addition, in this scenario the simulated patient was 
requesting a medication for his sister. This is because it is not uncommon in Saudi Arabia that a client 
is requesting medications for his/her relative and widely used in the literature from Saudi Arabia 
[54,102] and elsewhere [99]. 
 
In the pharyngitis scenario, the simulated patient told the pharmacist that he has a fever and has 
difficulty swallowing since the past two days. In the UTI scenario, the simulated patient told the 
pharmacist that his 27-year old sister (i.e. a childbearing age) is having dysuria and frequent urination. 











provided if the pharmacist inquired about it (including the pregnancy status). The simulated patients 
used lay language and refrained from using any jargon.  
 
Three sequential steps were followed before an antibiotic was dispensed or denied. First, the 
simulated patient asked for something to relieve the symptoms. Second, the simulated patient asked 
for something stronger if an antibiotic was not dispensed. In case an antibiotic was also denied, in the 
third step the simulated patient directly requested an antibiotic. In addition, if they were asked by the 
community pharmacists if they had other diseases or on other medications, the simulated patients 
would respond that they do not suffer from any other diseases and they do not take other 
medications. Moreover, the visits were made during the time it is possible to consult a physician either 
at a public or private clinic. To avoid forgetfulness, the investigators filled a standardized form 
including all obtained information immediately after leaving the pharmacy. 
 
2.3 Study population, sample size and Sampling technique  
The study population was community pharmacies in in Qassim region, Saudi Arabia. Qassim region 
consists of a capital city and 12 governorates with a total population of approximately 1.46 million 
[103,104]. In total, there were 422 community pharmacies in Qassim Region in 2017 [105]. However, 
since no up-to-date list of community pharmacies with full addresses was available to the research 
team at the time the study was conducted, a convenient sampling approach was adopted. To 
maximize sample diversity, enhance the generalizability of the findings, and minimize selection bias, 
the research team chose governorates based on population density. Consequently, the governorates 
were divided into zones (i.e. North, South, East and West), and the zones were further sub-divided 
into districts. The community pharmacies were selected from these districts using convenience 
sampling procedures, i.e. chosen based on practical criteria including geographical proximity, 
availability at the time of first visit, and easy accessibility. In this study, five main cities/governorates 
were finally chosen namely, Buraidah, Unaizah, Arras, Badaya and Albukairyah.  
 
Taking into consideration the feasibility and logistical issue as the study design requires simulated 
patients to visit each pharmacy four times over a one-year period (two visits in each phase for 
questionnaire administration and SCM), a quarter of all pharmacies in the region (n=116; 27.5%) were 
targeted and included in the study. No pharmacist refused to complete the questionnaire giving a 
100% response rate to their inclusion in the study. In each phase, the 116 pharmacies were visited for 
questionnaire administration. Similarly, in the SCM, all the 116 pharmacies were visited for one 
scenario, i.e. 58 visits for the pharyngitis scenarios and 58 visits for UTI. Each community pharmacy 
was visited for the same scenario in both phases. 
 
2.4 Data analysis 
Descriptive statistics such as frequency and percentages were used to summarize the data. The 
inferential statistics included the Chi square test (x2 e ), a d F e  e ac  e  e  a a e. 
The significance level was set at P value less than 0.05. Statistical analyses were performed using 
the Statistical Package for Social Sciences (SPSS) version 22.0 for Windows. 
 
2.5 Study approval 
The study protocol was reviewed and approved by the Scientific Research Committee at Unaizah 




3.1 The practice of DAwP 
In the cross-sectional questionnaire-based survey, before the law enforcement, 70.7 % of 
participating pharmacies believed that DAwP is common among them in Saudi Arabia. In the SCM, 
96.6%, and 87.7% of participants dispensed antibiotics without prescriptions for pharyngitis and UTI 
scenarios, respectively. After law enforcement, only 12.9% believed that DAwP is a common practice. 
This is confirmed by the SCM with only 12.1% and 5.2% of the visited pharmacies dispensing 
antibiotics without prescriptions for the pharyngitis and UTI scenarios, respectively. The comparison is 














3.2 Knowledge and perceptions towards DAwP 
In this study, there were only few statistically significant differences in terms of community 
a ac  ed e a d e ce  a d  DA P bef e a d af e  a  e f ce e .   
 
In fact, the majority of participants were aware that DAwP is illegal in Saudi Arabia (89.7% and 96.6%, 
pre- and post- law enforcement, respectively P = 0.179). Moreover, most participants stated that 
DAwP is contributing to the development of AMR (91.4% and 93.1%, pre- and post- law enforcement, 
respectively P = 0.242). Similarly, the majority of community pharmacists believed that AMR has 
become a public health issue (87.9% and 87.1 pre- and post- law enforcement, respectively P = 
0.898). Consequently, the majority believed that pharmacists should stop DAwP (82.8% and 82.8% 
pre- and post- law enforcement, respectively P = 0.99). However, after law enforcement, many 
pharmacists still had the feeling that if an antibiotic is not dispensed, patients will try to obtain it from 
another pharmacy. Similarly, many pharmacists reported that refusing DAwP will negatively affect 
their sales and profits (56.0% and 53.4% pre- and post- law enforcement, respectively P = 0.99). The 
results are presented in Table 2. 
 
 
3.3 Patient education and counselling about antibiotics 
Regarding patient education and counselling about the importance of adherence and appropriate use 
of antibiotics, the SCM revealed that in the cases where DAwP was practiced in the post-law 
enforcement period, there was a major improvement in counselling and education compared to the 
pre-enforcement phase. In fact, 85.7% and 100% of the simulated patients received counselling and 
education in the post-law enforcement for the pharyngitis and UTI scenarios, respectively, compared 
to only 50% and 52% in the pre-law enforcement phase. Moreover, the results showed a major 
difference in the step in which the antibiotic was dispensed. Before law enforcement, this was mainly 
in the 1st step (i.e. 85.7% and 74% for pharyngitis and UTI, respectively) while the opposite occurred 
after the enforcement as DAwP mostly occurred after the patients i sisted in Step 3 (57.1% and 
66.7% for pharyngitis and UTI, respectively in Step 3).  
 
In addition, while the reason behind refusing dispensing antibiotic without prescription was a ea -
e a ed ea   e a  f ca e   the pre-law enforcement simulated patient survey, the 
contrary was true in the post-law enforcement simulated patient survey with the majority stating a 
e a - e a ed ea . De a  f e e  f a c a  be ee  e a d -law 
enforcement simulated patient survey concerning c  a ac  be a urs while practicing 




We believe this is the first study in Saudi Arabia that has evaluated the impact of the regulatory 
intervention to enforce the laws prohibiting DAwP. The study findings showed that enforcement of the 
law coupled with substantial fines resulted in a significant decrease in the prevalence of DAwP. It was 
reduced significantly by more than 80% after law enforcement and fines (Figure 2, Table 3).  
 
This reduction would appear to be greater than the significant reductions in DAwP seen in Chile, 
Mexico, and the Republic of Srpska, following greater enforcement of the laws and appreciably 
greater than seen with the combined studies in Brazil, Colombia and Venezuela (Table 1). This 
reduction in Saudi Arabia may have been helped by the level of potential fines coupled with the 
explanation for denying an antibiotic without a prescription.  Unlike during the pre-law enforcement 
phase, DAwP only happened post phase after considerable pressure from patients (Step 3  Table 3). 
In addition, when an antibiotic was denied in the post-law enforcement phase, the reason was mostly 
regulations-related, e  a   ea - e a ed   e fe  ca e  a b c  de ed  e e-
law enforcement phase. A  a e , c a  a e  e ec a  c   a  iven the 
pressure that patients or parents can place on pharmacists to dispense an antibiotic without a 
prescription in a number of countries [20,49,66,74,100]. After law enforcement, patient counselling 
and education about antibiotics also increased when antibiotics were dispensed without prescription 
(Table 3).  This is encouraging as there are a number of key issues that need to be discussed with 
patients when dispensing antibiotics including allergies, dosing and the need to complete the full 
course [34,73,74,76]. These findings in Saudi Arabia compare very favourably with a recent study in 
UAE where only 1.4% of the patients were given instructions on how to use antibiotics and none were 











Of interest is that there appeared to be no significant changes in the knowledge and perceptions of 
community pharmacists between pre- and post-law enforcement on many aspects related to DAwP 
(Table 2). These included their awareness of the existing law prohibiting dispensing antibiotics without 
prescription, the negative impact of DAwP and the associated issues with antimicrobial resistance. 
This may reflect ongoing programmes within the universities t  e a ac  ed e 
regarding antibiotics, AMR and the regulations surrounding DAwP. This is in line with national action 
plan of Saudi Arabia on combating AMR. Objective two of this plan stated that AMR and related topics 
should be emphasized in the professional programs of health colleges including Pharmacy Colleges 
[107]. In addition, several awareness programs are currently being conducted by Pharmacy colleges 
in Saudi Arabia targeting both healthcare professionals and the general public regarding the rational 
use of antibiotics [108]. However, still a large proportion of pharmacists believed that patients would 
seek antibiotics from other community pharmacies if not dispensed, which is a continuing concern. 
This again highlights the importance that interventions, such as law enforcement, should be 
accompanied by strategies that raise awareness about, and promote appropriate use, of antibiotics 
among all key stakeholders including healthcare professionals and patients [12,13,70,77,109].  
 
Our findings indicate the need to introduce additional measures and interventions in Saudi Arabia 
targeting all key stakeholders including physicians, patients and the general public to further enhance 
the appropriate use of antibiotics. This can be undertaken via b c a a e e  ca a , a e  
materials and other interventions in a more holistic approach given some of the findings seen in other 
countries and the need to sustain current low levels of DAwP in Saudi Arabia (Table 1). These are of 
great importance as the current evidence derived from the studies utilizing theory of planned 
behaviour to investigate predictors of intention to dispense antibiotics by community pharmacists 
suggests that attitudes towards antibiotics in terms of their benefit and harms had strong influence on 
a ac  e   d e e a b c . I  add , b ec e  including pressure from 
patients and easy access to antibiotics from other pharmacies do influence a ac  ac ce 
[20,33,110,111]. In addition, some community pharmacists in this study still believed there is no 
problem if antibiotics are dispensed without a prescription. This is in line with the findings of Amin et 
al. 2017 from Egypt in which some community pharmacists believed there is no problem in dispensing 
antibiotics without a prescription, i.e. they a ed e - a fea a ce  c e   violated 
[110]. These are important findings and need to be considered during educational and other 
interventions to ensure the sustainability of any intervention. We will be monitoring such 
developments in the future.  
 
Currently, pharmacists in Saudi Arabia are not authorized legally to dispense antibiotics without a 
prescription for all conditions. However, some arguments are raised regarding this legal limitation and 
strict limitation might not be the best option. It is being argued that dispensing antibiotics for some 
specific clinical situations could be supported especially in conditions that can be identified by simply 
interviewing the patient without the need to perform clinical exams. For example, in the UK, 
pharmacists can legally dispense azithromycin to patients with positive chlamydia test results and in 
New Zealand, pharmacists can supply trimethoprim for short-term treatment of an uncomplicated UTI 
[16]. However, to consider this in Saudi Arabia there needs to be considerable training of community 
pharmacists on antimicrobial stewardship programs to ensure appropriate use of antibiotics for these 
clinical situations. Moreover, it should further investigated whether such a step is necessary in terms 
of accessibility to antibiotics especially if access to primary care physicians is widely available via a 
large number of primary care centers and medical polyclinics, which is unlike the situation in the UK 
where there can be extensive waiting times to see general practitioners [112]. In 2017 in Saudi 
Arabia, there were 2393 primary healthcare centers (public sector) and 1338 medical polyclinics 
(Private sector) for a population of approximately 34.5 million [105]. 
The study has several implications. It demonstrates that enforcement of the law coupled with strong 
measures such as fines and potential closure of pharmacies can have an appreciable impact on 
DAwP. This compares with situations where there is limited enforcement of the law. Other measures 
though are also needed to improve future prescribing and dispensing of antibiotics to address the 
many reasons for continued abuse of antibiotics. These include education among patients and the 
public especially that taking antibiotics for viral infections such as colds and sore throats will not 
speed up recovery and may lead to side-effects and the build-up of resistance. In addition, continued 
education among physicians about antibiotics and AMR coupled with monitoring of their prescribing 
and possible incentives to reduce inappropriate antibiotic prescribing as well as education and 
guidance for community pharmacists. Community pharmacists are especially important as often they 











throats and UTIs [30,40,113]. This is critical in lower and middle income countries. Consequently, 
targeting DAwP is essential across many countries especially LMICs given the influence this has on 
enhancing inappropriate antibiotic utilisation especially in self-limiting conditions. To date, there have 
only been a limited number of studies that have demonstrated the influence of different measures to 
reduce DAwP. This study in Saudi Arabia adds to the knowledge base, and is especially important for 
countries in the Middle East where this practice has been prevalent despite being illegal.  
 
4.1 Strengths and Limitations  
The study had a number of strengths. The study adopted a multi- methods design to assess real 
practice by employing a non-traditional method (i.e. a simulated client method). Moreover, the study 
targeted community pharmacies from five different cities of the region. However, there are some 
limitations in the study. Firstly, we employed a convenience sampling method to collect the data. 
However, this was inevitable due to several logistical and practical barriers. Secondly, the study 
included only 116 pharmacies. However, given the complexity of the design, i.e. the need to visit each 
community pharmacy four times over one year by different data collectors, a larger sample size was 
not feasible. The study was also only conducted in one administrative region of Saudi Arabia, i.e. 
Qassim region, again due to logistical and practical barriers. Consequently, the findings might not be 
generalizable to the other 12 administrative regions of the country. In addition, whilst the same 
pharmacies were visited in both phases of the study, this might not necessarily be the same 
pharmacist since in some community pharmacies there were more than one pharmacist working in 
the same pharmacy. However, we believe it is the same practice adopted at the level of the 
pharmacy. However, despite these limitations, we believe the study finding are robust and provide 
future guidance to the health authorities in Saudi Arabia and wider. 
 
5. Conclusion and Recommendations 
We believe the study findings show that law enforcement including the potential for substantial fines 
and loss of the licence to practice are effective in reducing DAwP. The prevalence of DAwP was 
significantly decreased by more than 80% after law enforcement.  
 
However, we believe there is still further scope for improvement. This includes greater educational 
activities among all key stakeholder groups including patients to reduce expectations of being 
prescribed or dispensed an antibiotic for essentially self-limiting conditions. This is particularly 
important as restricting access to the over-the-counter antibiotics is only one component among many 
to enhance the future rational use of antibiotics and reduce AMR rates.  
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x The Albanian Ministry of Health recently established a task force to reduce  
DAwP through improved inspections and fines for community pharmacists 
for abusing the system in view of concerns with their  knowledge regarding 
antibiotics and concerns with the current extent of DAwP 
x In the first months of implementation, over 100 community pharmacies have 
been inspected with approximately one fifth of pharmacies being fined for 
dispensing a medicine without a prescription  
x The impact of these measures is being monitored in case additional 
initiatives are needed to further reduce DAwP 
Brazil [82-85]  x There have always been restrictions on DAwP among public pharmacies in 
Brazil where patients can receive their medicines free of charge. However, 
in 2010 following the increase in multi-resistant KPC (Klebsiella 
Pneumoniae Carbapenemase), regulations were tightened for private 
pharmacies in which they had to keep a copy of the prescriptions and since 
April 2013 antibiotics have been included in the National Controlled 
Substances Management System 
x In their study, Santa-Ana-Tellez et al (2013) found a tempering of the 
increase in antibiotic consumption in Brazil following tighteneing of the 
regulations 
x In their study, Moura et al (2015) found a significant decrease in overall 
antibiotic consumption of 1.87 DDDs/ one thousand inhabitants per day (p < 
0.001) among private pharmacies post changes in the legislation but, as 
expected, no difference among public pharmacies  
x In their study, Lopes-Junior et al (2015) among approximately 3000 private 
pharmacies found sales of amoxicillin falling by approximately 30%, 
tetracyclines by 30.5%, sulphonamides by 28.5%, and macrolides by 25%, 
post legislation despite the general growth in the pharmaceutical market 
Chile [82,86] x Chile was one of the first countries in Latin America to introduce greater 
enforcement of the law to reduce DAwP among private sector pharmacies 
in 1999 following concerns with increasing antimicrobial consumption and 
AMR 
x Regulations were enhanced by antibiotics being removed from the list of 
medicines having sales incentives in pharmacies 
x Antimicrobial consumption decreased from 12.3 DID before the intervention 
to 8.5 DID just after the enforcement (in 2000). This decrease was helped 
by the instigation of public information campaigns before and during the 
implementation of greater enforcement of the regulations 
x However, there has been a slow increase in antimicrobial utilisation since 
2002 suggesting that the effects of the intervention wear off unless 
continually monitored and further initiatives introduced when pertinent 
Colombia 
[82,86,87] 
x Colombia started to regulate DAwP in 2005 in the capital city (Bogotá)  
x There was a modest impact on overall retail sales of antibiotics in the three 
years (12 quarters) in Colombia (-1.00 DIDs) after the changes in the 
regulations 
x However, a follow up study five years after implementation of the 
regulations found that 80.3% of pharmacies visited still did not comply with 
the regulations 
x This may help to explain the modest results seen initially prompting calls for 
greater enforcement of the law  
Mexico [82,88] x The government in Mexico in 2010 implemented policies to enforce existing 
laws regarding restricting DAwP and only dispensing antibiotics to patients 
presenting with a prescription 
x The regulation requires antibiotic prescriptions to be retained and registered 
in pharmacies, with fines imposes fines on pharmacy owners for non-
compliance 











with the trend accelerating after greater enforcement of the legislation 
x There was also an appreciable seasonal reduction in the use of penicillins in 
Mexico after greater enforcement of the legislation 
Namibia [89,90]  x There are regulations in place banning DAwP in Namibia helped by 
universal access to healthcare including medicines and regular monitoring 
of pharmacies 
x A recent survey in Namibia involving 100 households in the informal sector 
found that parents regularly self-medicated URTIs among their children 
including for common colds and influenza 
x However, typically treat with cold/flu medication as well as paracetamol and 
decongestants rather than antibiotics demonstrating that the regulations are 
working. This is helped in Namibia by medicines being free-of-charge in 
primary healthcare centres 
Republic Srpska 
[40,70,91]  
x The Republic of Srpska has been active over a number of years to improve 
the prescribing and dispensing of antibiotics in ambulatory care following 
concerns with high rates of DAwP  
x Activities involve continual education of pharmacists and pharmacist 
technicians - including published guidelines for pharmacy personnel as well 
as continual inspections of community pharmacies since by law antibiotics 
are restricted to prescription only medicines in the Republic 
x Recent studies have shown low levels of DAwP (at 18.5% of pharmacies vs. 
58% previously) and combined activities including physician and patient 
education resulted in the Republic having one of the lowest utilisations of 
antibiotics in recent years compared with similar neighbouring countries  
Turkey 
[78,79,92]  
x In 2014, the Turkish health authorities implemented an electronic 
prescription system to track prescription data as well as provide feedback to 
physicians in line with the 2014  2017 National Action Plan to enhance the 
appropriate use of antibiotics in Turkey given high rates versus other 
European countries. This is the c e e e a ace ca  ac  a d 
ace  e  which tracks medicines from their production to dispensing 
x The regulations preventing DAwP include potential fines for pharmacists 
following abuse, which have also been in operation since 2014 aided by the 
ac  a d ace  e  
x It is envisaged that future studies will show an appreciable decrease in 
DAwP in Turkey following these changes with enhanced monitoring of the 
prescribing and dispensing chain 
Venezuela 
[82,86]  
x In 2006, Venezuela implemented a policy to reduce DAwP among three 
groups of antibiotics namely macrolides, quinolones and third generation 
cephalosporins, without any public awareness campaigns 
x There was though no change in their utilisation patterns with enforcement 
made via only formal government publications and not followed up for 
instance with any increase pharmacy supervision or any pharmacy closures 
or financial sanctions for non-compliance 
Vietnam [72]  x Three interventions and initiatives were applied sequentially in Vietnam to 
help reduce the extent of DWaP. These included (i) greater regulatory 
enforcement, (ii) education among pharmacists especially regarding 
uncomplicated acute respiratory infection (ARI) and (iii) peer influence 
 
x For ARI, antibiotic dispensing for ARI decreased appreciably following the 
interventions compared with a control group of pharmacists. There were 















Table 2 C  a ac  K ed e a d e ce  a d  DA P* 








D   
n (%) 
p-value 
DAwP is legal in Saudi Arabia 
Before 8 (6.9) 104 (89.7) 2 (1.7) 
0.179 
After 2 (1.7) 112 (96.6) 2 (1.7) 
DAwP is common among community 
pharmacists in Saudi Arabia Before 82 (70.7) 20 (17.2) 14 (12.1) < 0.001* 
After 15 (12.9) 92 (79.3) 8 (6.9) 
Do you think there is any problem if you 
dispense medication without prescription Before 102 (87.9) 14 (12.1) 0 (0.0) 0.033* 
After 89 (76.7) 25 (21.6 ) 2 (1.7) 
DAwP is contributing to the development 
of antimicrobial resistance Before 106 (91.4) 8 (6.9) 1 (0.9) 0.242 
After 108 (93.1) 4 (3.4 ) 4 (3.4) 
Antibiotic resistance has become a public 
health issue Before 102 (87.9) 9 (7.8) 3 (2.6) 0.898 
After 101 (87.1) 11 ( 9.5) 4 (3.4) 
DAwP is contributing to the inappropriate 
use of antibiotics by patients Before 101 (87.1) 11 (9.5) 4 (3.4) 0.93 
After 98 (84.5) 11 (9.5) 5 (4.3) 
Pharmacists should stop DAwP Before 96 (82.8) 18 (15.5) 2 (1.7) 
0.99 
After 96 (82.8) 17 (14.7) 3 (2.6) 
I encourage patients to consult the 
physician and get a prescription Before 114 (98.3) 2 (1.7) 0 (0.0) 0.102 
After 108 (93.1 ) 8 (6.9 ) 0 (0.0) 
When patients feel that they need an 
antibiotic, if not dispensed, they will try to 
obtain it from another pharmacy 
Before 107 (92.3) 2 (1.7) 7 (6.0) 
< 0.001* 
After 78 (67.2 ) 12 (10.3) 26 (22.4) 
Refusing DAwP will negatively affect 
sales and profits Before 65 (56.0) 46 (39.7) 5 (4.3) 0.99 











Table 3: C  a ac  be a  e ac c  DA P (58 visits for each scenario at 
each point of time before and after law enforcement) 
 
Item Pharyngitis scenario UTI scenario 
Before N (%) After N (%) Before N (%)* After N (%) 
Dispensed antibiotic without prescription 56 (96.6) 7 (12.1)** 50 (87.7) 3 (5.2)** 
 
Educated about the importance of adherence 










Step in which antibiotic was dispenseda     
      1st step 48 (85.7) 1 (14.3) 37 (74.0) 1 (33.3) 
      2nd step 3 (5.4) 2 (28.6) 4 (8.0) 0 (0) 
      3rd step 5 (8.9) 4 (57.1) 9 (18.0) 2 (66.7) 
Reason behind refusing dispensing antibiotic 
without prescriptiona 
    
      Health-related reason 2 (100) 2 (4.0) 5 (71.4) 5 (9.1) 
      Regulations-related reason 0 (0) 49 (96.0) 2 (28.6) 50 (90.9) 
NB = DAwP = dispensing antibiotics without prescription. *Data for one visit is missing. **Statistically significant at 
P < 0.001. a These items were presented descriptively as statistical analysis was not attempted because of the 













Figure 1: The design and flow of the study 
 
 




Figure 2: The practice of DAwP before and after the law enforcement  
 
 
         NB: * indicates statistically significant at P < 0.001.  
